Characterization of the ant ige nie epitope recognized by tumor selective antibody

I. M. Rose, D. L. Denardo, C. F. Meares

Research output: Contribution to journalArticle

Abstract

The selcriiviiy of Lym-1 for malignant li-jympliocytns makes this mono clonal antibody a promising randidaic for tho d('li\''i\ <>| toxit agents îo nia lignant It-cells. The original imrnunogen ued for the devflopmrnl of l.ym 1 was Raji Hnrkitt's lyniphoma cell nuclei [Kpstein AI,. Marder RJ. Winter -IX. Stathopouluh K. ('hen FM. Parker .IW. 'ray'or ('H I 17) Cancer Res -17:S:j()]. The Lym-1 antigen was characterised at that lime ,is a polymorphic HLA-DR variant. UV prepared an affinity column using immnhili/,ed I.yni-1 tn isolate t lie Lym-1 antigen from Raji cell lysate. Iiiniiunologi( al characierizalion of t he immnnoafïinity [mrified Lym-1 antigen on western blots led to the conclusion t hat the antigen i- thebeta chain of ULA-DRK). This was coitfinned by Ld man sequeiK'ine, oi the isolated polypeptide chain. V\estern blot.s fnrtiier stiuu that the Lym-1 epitope is only rerognued if the beta chain disnlfulr bonds are intact. These results imply that Lym 1 binds a discontinuous' epiîope on the beta chain of HLA-DR1Ü.

Original languageEnglish (US)
JournalFASEB Journal
Volume11
Issue number9
StatePublished - 1997
Externally publishedYes

Fingerprint

Neoplasm Antibodies
Ants
epitopes
Tumors
Epitopes
Formicidae
antigens
Antigens
neoplasms
antibodies
Antibodies
HLA-DR1 Antigen
Monoclonal antibodies
HLA-DR Antigens
cell nucleus
Cell Nucleus
hens
polypeptides
monoclonal antibodies
Western blotting

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

Rose, I. M., Denardo, D. L., & Meares, C. F. (1997). Characterization of the ant ige nie epitope recognized by tumor selective antibody. FASEB Journal, 11(9).

Characterization of the ant ige nie epitope recognized by tumor selective antibody. / Rose, I. M.; Denardo, D. L.; Meares, C. F.

In: FASEB Journal, Vol. 11, No. 9, 1997.

Research output: Contribution to journalArticle

Rose, I. M. ; Denardo, D. L. ; Meares, C. F. / Characterization of the ant ige nie epitope recognized by tumor selective antibody. In: FASEB Journal. 1997 ; Vol. 11, No. 9.
@article{24e19e4a39394936aa76341c56cdf591,
title = "Characterization of the ant ige nie epitope recognized by tumor selective antibody",
abstract = "The selcriiviiy of Lym-1 for malignant li-jympliocytns makes this mono clonal antibody a promising randidaic for tho d('li\''i\ <>| toxit agents {\^i}o nia lignant It-cells. The original imrnunogen ued for the devflopmrnl of l.ym 1 was Raji Hnrkitt's lyniphoma cell nuclei [Kpstein AI,. Marder RJ. Winter -IX. Stathopouluh K. ('hen FM. Parker .IW. 'ray'or ('H I 17) Cancer Res -17:S:j()]. The Lym-1 antigen was characterised at that lime ,is a polymorphic HLA-DR variant. UV prepared an affinity column using immnhili/,ed I.yni-1 tn isolate t lie Lym-1 antigen from Raji cell lysate. Iiiniiunologi( al characierizalion of t he immnnoaf{\"i}inity [mrified Lym-1 antigen on western blots led to the conclusion t hat the antigen i- thebeta chain of ULA-DRK). This was coitfinned by Ld man sequeiK'ine, oi the isolated polypeptide chain. V\estern blot.s fnrtiier stiuu that the Lym-1 epitope is only rerognued if the beta chain disnlfulr bonds are intact. These results imply that Lym 1 binds a discontinuous' epi{\^i}ope on the beta chain of HLA-DR1{\"U}.",
author = "Rose, {I. M.} and Denardo, {D. L.} and Meares, {C. F.}",
year = "1997",
language = "English (US)",
volume = "11",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "9",

}

TY - JOUR

T1 - Characterization of the ant ige nie epitope recognized by tumor selective antibody

AU - Rose, I. M.

AU - Denardo, D. L.

AU - Meares, C. F.

PY - 1997

Y1 - 1997

N2 - The selcriiviiy of Lym-1 for malignant li-jympliocytns makes this mono clonal antibody a promising randidaic for tho d('li\''i\ <>| toxit agents îo nia lignant It-cells. The original imrnunogen ued for the devflopmrnl of l.ym 1 was Raji Hnrkitt's lyniphoma cell nuclei [Kpstein AI,. Marder RJ. Winter -IX. Stathopouluh K. ('hen FM. Parker .IW. 'ray'or ('H I 17) Cancer Res -17:S:j()]. The Lym-1 antigen was characterised at that lime ,is a polymorphic HLA-DR variant. UV prepared an affinity column using immnhili/,ed I.yni-1 tn isolate t lie Lym-1 antigen from Raji cell lysate. Iiiniiunologi( al characierizalion of t he immnnoafïinity [mrified Lym-1 antigen on western blots led to the conclusion t hat the antigen i- thebeta chain of ULA-DRK). This was coitfinned by Ld man sequeiK'ine, oi the isolated polypeptide chain. V\estern blot.s fnrtiier stiuu that the Lym-1 epitope is only rerognued if the beta chain disnlfulr bonds are intact. These results imply that Lym 1 binds a discontinuous' epiîope on the beta chain of HLA-DR1Ü.

AB - The selcriiviiy of Lym-1 for malignant li-jympliocytns makes this mono clonal antibody a promising randidaic for tho d('li\''i\ <>| toxit agents îo nia lignant It-cells. The original imrnunogen ued for the devflopmrnl of l.ym 1 was Raji Hnrkitt's lyniphoma cell nuclei [Kpstein AI,. Marder RJ. Winter -IX. Stathopouluh K. ('hen FM. Parker .IW. 'ray'or ('H I 17) Cancer Res -17:S:j()]. The Lym-1 antigen was characterised at that lime ,is a polymorphic HLA-DR variant. UV prepared an affinity column using immnhili/,ed I.yni-1 tn isolate t lie Lym-1 antigen from Raji cell lysate. Iiiniiunologi( al characierizalion of t he immnnoafïinity [mrified Lym-1 antigen on western blots led to the conclusion t hat the antigen i- thebeta chain of ULA-DRK). This was coitfinned by Ld man sequeiK'ine, oi the isolated polypeptide chain. V\estern blot.s fnrtiier stiuu that the Lym-1 epitope is only rerognued if the beta chain disnlfulr bonds are intact. These results imply that Lym 1 binds a discontinuous' epiîope on the beta chain of HLA-DR1Ü.

UR - http://www.scopus.com/inward/record.url?scp=33750252507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750252507&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33750252507

VL - 11

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 9

ER -